A novel strategy of C‐myc oncogene in NK activity regulation not related to the W6/32 MHC class‐I epitope
- 18 July 1994
- journal article
- Published by Wiley in International Journal of Cancer
- Vol. 58 (1) , 123-128
- https://doi.org/10.1002/ijc.2910580120
Abstract
The C‐myc gene encodes a nuclear protein whose precise function is still not folly understood. Introduction of a c‐myc gene into a number of cell lines leads to an increase in their susceptibility to NK‐cell lysis. It was reported earlier that c‐myc can induce a decrease in the membrane expression of the MHC class‐1 molecules and this may be one of the factors that render target cells relatively more susceptible to NK lysis. In this contribution, we show, in a human LCL line transfected with a constitutively active c‐myc gene, an increased sensitivity to NK lysis, which correlates with an augmented effector‐target binding ability of c‐myc‐transfected LCLs and with a high 1CAM‐1 expression rather than with down‐regulation of MHC class‐l W6/32 epitope expression.Keywords
This publication has 21 references indexed in Scilit:
- MHC class I expression on prelymphomatous and lymphomatous B-cells is not inhibited by an Eμ-myc transgeneEuropean Journal Of Cancer, 1993
- Reduced expression of major histocompatibility complex class I free heavy chains and enhanced sensitivity to natural killer cells after incubation of human lymphoid lines with β2‐microglobulinEuropean Journal of Immunology, 1993
- Over‐expression of c‐myc increases the sensitivity of epstein‐barr virus immortalized lymphoblastoid cells to non‐MHC‐restricted cytotoxicityInternational Journal of Cancer, 1993
- c-myc-induced natural killer cell sensitivity of human melanoma cells is reversed by HLA-B27 transfectionEuropean Journal of Immunology, 1992
- Differential mRNA levels of c‐myc, c‐fos and MHC class I in several clones of a murine fibrosarcomaInternational Journal of Cancer, 1991
- How do peptides associate with MHC class I molecules?Immunology Today, 1991
- Suppression of class I human histocompatibility leukocyte antigen by c-myc is locus specific.The Journal of Experimental Medicine, 1989
- Transformation and Plasmacytoid Differentiation of EBV-Infected Human B Lymphoblasts by ras OncogenesScience, 1989
- Pathogenesis of Burkitt lymphoma: Expression of an activated c-myc oncogene causes the tumorigenic conversion of EBV-infected human B lymphoblastsCell, 1987
- Host resistance directed selectively against H-2-deficient lymphoma variants. Analysis of the mechanism.The Journal of Experimental Medicine, 1985